首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma
【2h】

Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma

机译:口腔鳞状细胞癌中BIRC5 / Survivin表达的组织学和生物信息学综合分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Survivin is a well-known protein involved in the inhibition of apoptosis in many different cancer types. The aim of this study was to perform an integrated bioinformatic and histologic analysis in order to study the expression and prognostic role of Survivin and its related gene BIRC5 in oral cancer. Publicly available databases were accessed via Gene Expression Omnibus and Oncomine, in addition raw data from The Cancer Genome Atlas (TCGA) were also obtained in order to analyze the rate of gene mutation, expression and methylation in patients with oral squamous cells carcinoma (OSCC). Immunohistochemistry (IHC) was also performed in order to evaluate the nuclear and cytoplasmic expression of Survivin and their correlation with cell proliferation in samples from OSCC patients. Results of this study revealed that Survivin is rarely mutated in OSCC samples and upregulated when compared to non-cancerous tissue. A negative correlation between the methylation of the island cg25986496 and BIRC5 mRNA expression was detected from TCGA data. IHC staining revealed that cytoplasmic (and not nuclear) expression of Survivin is associated with poor overall survival in OSCC patients, while the nuclear expression correlates with higher proliferation rate. In addition, data from TCGA database revealed that BIRC5 gene expression is an independent prognostic factor for OSCC patients.
机译:Survivin是一种众所周知的蛋白,在许多不同类型的癌症中均参与细胞凋亡的抑制作用。这项研究的目的是进行综合的生物信息学和组织学分析,以研究Survivin及其相关基因BIRC5在口腔癌中的表达和预后作用。通过Gene Expression Omnibus和Oncomine访问公开可用的数据库,此外还获得了癌症基因组图谱(TCGA)的原始数据,以便分析口腔鳞状细胞癌(OSCC)患者的基因突变,表达和甲基化率。为了评估OSCC患者样品中Survivin的核和细胞质表达及其与细胞增殖的相关性,还进行了免疫组织化学(IHC)。这项研究的结果表明,与非癌性组织相比,OSCC样品中的Survivin很少发生突变并被上调。从TCGA数据中检测到岛cg25986496的甲基化与BIRC5 mRNA表达之间呈负相关。 IHC染色表明,OSCC患者中Survivin的细胞质表达(而不是核表达)与总体生存期差有关,而核表达与更高的增殖率相关。此外,来自TCGA数据库的数据显示BIRC5基因表达是OSCC患者的独立预后因素。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号